Mologic's Outlook
"In a world of changing and evolving Health Care delivery models - with a drive towards cost reduction - The use of these therapies in an appropriate manner become paramount"
Mologic's early research success in the establishment of a working wound protein-based diagnostic prototype, will result in the worlds first diagnostic product.
The willingness of the majority to say "No", "Never" and "Can't" and then give up, creates a fabulous opportunity for those of us who say:
"Difficult, Yes!, Impossible, No!"
OUr clinical areaS
Mologic is involved in the following clinical areas:
* Wound Care: The management of chronic wounds is a global issue, costing health care services billions of pounds per annum. Wound diagnostic indicators will provide aids to facilitate de-skilled assessment, allowing appropriate ongoing treatment. Mologic is not only well advanced for POC diagnostics, but also research and development of point-of-care diagnostic indicators targetted at chronic wounds.
* Women's Health: Mologic's has a strong commitment to develop innovative diagnostic products and technologies directed to women's health. Our developing technology includes the following applications which are major areas of widespread significance to women's health and well-being:
- Pregnancy
- Fertility
- Osteoporosis
- Infection
* Oncology: The most exciting and potentially beneficial research area in our portfolio. These include the following areas:
- Choriocarcinoma
- Prostate
- Colorectal
- Gastric
Clinical and Academic Collaborations
Mologic is also involved in a number of clinical and academic collaborations.
Click Here to find out more.